IPO, OpenAI
Digest more
Navan will be the first large company to debut without a fully functioning Securities and Exchange Commission.
Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 ...
OpenAI is laying the groundwork for an initial public offering that could value the company at up to $1 trillion, three ...
Navan priced its IPO at $25 per share, aiming to raise around $700 million, with shares set to begin trading on Nasdaq. The ...
2d
Renaissance Capital Opens New Circle Internet Group (NASDAQ: CRCL) Position: Is the New IPO a Buy?
According to a filing with the Securities and Exchange Commission dated October 20, 2025, Renaissance Capital reported a new ...
The IPO preparations follow a restructuring of OpenAI completed on October 28 that reduced the company’s reliance on ...
The challenge - MapLight Therapeutics exists to open possibilities, unlocking new treatments for patients long underserved by ...
Lenskart IPO: Shark Tank India judge Peyush Bansal-backed eyewear company, Lenskart Solutions, completed its anchor investors ...
Netskope expects a major lift from its recently completed IPO, which has put the company on the same playing field alongside ...
India's markets regulator on Thursday barred Gretex Corporate Services Ltd from taking on new merchant banking assignments ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback